News

Targeted Oncology2d
Krivak on PARP Inhibitors and Maintenance Therapy in Ovarian Cancer
In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...
Frontiers18d
The prognostic value of growth pattern-based grading for mucinous ovarian carcinoma (MOC): a systematic review and meta-analysis
The following search terms were used to identify relevant studies on ovarian cancer: “Carcinoma, Ovarian Epithelial”, “Epithelial Carcinoma, Ovarian”, “Ovarian Epithelial Carcinomas”, whereas the ...
Frontiers23d
Adipose tissue loss during neoadjuvant chemotherapy: a key prognostic factor in advanced epithelial ovarian cancer
Background: Advanced epithelial ovarian cancer (EOC) patients often receive neoadjuvant platinum-based chemotherapy (NAC), with interval surgery (after three cycles of chemotherapy) considered as a ...
Medscape27d
Trop-2 Protein Overexpression is an Independent Marker for Predicting Disease Recurrence in Endometrioid Endometrial Carcinoma
Trop-2 is a glycoprotein involved in cellular signal transduction and is differentially overexpressed relative to normal tissue in a variety of human adenocarcinomas, including endometrioid ...
Associated Press27d
Blood test for ovarian cancer misses some Black and Native American patients, study finds
Friday, Oct. 24, 2014. (AP Photo/Pablo Martinez Monsivais, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] A common blood test may miss ovarian cancer in some Black and ...